Methods, compounds, pharmaceutical compositions and kits are described for
treating or preventing CNS and amyloid associated disease. Also described
are methods, compounds, pharmaceutical compositions and kits for
detecting, diagnosing, monitoring and treating or preventing CNS and
amyloid associated disease.